Company adopts Edge CTMS in Japan as part of rapid global expansion NEW YORK --(BUSINESS WIRE)--Feb. 20, 2018-- Santen Pharmaceutical Co., Ltd , is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS (Clinical Trial Management System) to support its clinical trial
Industry-leading Data Management Provider Adopts Rave Imaging to Optimize Workflow, Simplify Image and Data Collection, and Improve Efficiency in Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 15, 2018-- Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC , an
NEW YORK --(BUSINESS WIRE)--Feb. 14, 2018-- Medidata (NASDAQ:MDSO) has been named to Barron’s first annual list of the “ 100 Most Sustainable Companies ” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.
Leading clinical research organization moves to the industry’s only unified platform to maximize efficiencies and outcomes NEW YORK --(BUSINESS WIRE)--Feb. 13, 2018-- Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the
Life Science Buyers Identify Top Criteria to Support the New Generation of Trials Edge Strategic Monitoring is Only RBM Solution to Address 95% of TransCelerate Technical Requirements and be Fully Compliant with ICH GCP E6 (R2) Requirements NEW YORK --(BUSINESS WIRE)--Feb.
Events in Basel , Frankfurt and London Bring Together Industry Leaders to Reinvent Technology’s role in Transforming Clinical Development NEW YORK --(BUSINESS WIRE)--Feb. 12, 2018-- Medidata Solutions (NASDAQ:MDSO), is pleased to announce the 13 th annual NEXT Conference series will commence in
Majority of virtual trials are now run on Medidata Clinical Cloud®, the industry’s only unified eClinical platform to fully support all manner of pragmatic study designs NEW YORK --(BUSINESS WIRE)--Feb. 8, 2018-- Medidata (NASDAQ:MDSO) announced today that its virtual trials platform, Engage, is
Full-year total revenue of $545.5 million , representing 18% year-over-year growth Full-year GAAP net income of $44.4 million , or $0.74 per diluted share, up 53% year-over-year Total multi-year unadjusted subscription backlog 1 of $1.0 billion as of December 31, 2017 , up 39% year-over-year
Advanced Analytics Empower Life Sciences Companies and CROs to Tackle Today’s Most Complex Trials NEW YORK --(BUSINESS WIRE)--Feb. 6, 2018-- Targeted therapies create new opportunities for patients, but can require complex trial design to achieve their promise.
Partnership will democratize access to clinical trials and help community health systems find and enroll eligible patients at unprecedented scale NEW YORK and SAN FRANCISCO , Jan. 31, 2018 /PRNewswire/ -- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data